JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"
Development and application of LC-MS MS detection method for novel mRNA drug delivery system LNP in mouse plasma and tissues
2026.07.28
Validation of a highly sensitive ICP-MS method for the determination of Platinum in Human Urine and Feces application to clinical excretion studies with Pt(0506)101
2026.07.28
Quantitative bioanalysis of antibody-conjugated payload in human serum using a hybrid immuno-capture LC–MSMS approach Assay development, validation, and a case study
2026.07.28
IOP-lowering Effect of Rhopressa in Normotensive Rabbit, Dog and Monkey Eyes
2026.07.28
Dry Eye in Ovariectomized Cynomolgus Monkeys - A 54 Months Follow-up Study
2026.07.28
A Survey of Spontaneous Cataract in Senior Cynomolgus Monkeys with or without Diabetes
2026.07.28
Validation of an MSD ECl method for analysis of antibodyagainst ipilimumab in monkey serum
2026.07.28
Development of a LC-MSMS method for the determination of thymosin in humanplasma Application to a pharmacokinetic study
2026.07.28
Development of a LC-MSMS method for the determination ofliraglutide in monkey serum Application to a pharmacokineticstudy in monkeys
2026.07.28
Automated control and monitoringof inhalation exposure conditions inGLP studies improves GLp compliance